Gilead Seeks US Approval For Drug That Shortens Covid Recovery Time

Gilead Sciences Inc has filed an application with the U.S. Food and Drug Administration seeking full approval for remdesivir, its experimental COVID-19 drug currently used under emergency...

from NDTV News - Latest https://ift.tt/31H4RvQ
via IFTTT

Advertisement